期刊文献+

液基细胞学联合HPV分型检测在妊娠合并宫颈上皮内瘤变患者的应用 被引量:12

Liquid-based cytology in combination with human papilloma virus test for cervical intraepithelial neoplasia during pregnancy
下载PDF
导出
摘要 目的:应用液基细胞学联合HPV分型方法检测妊娠合并宫颈上皮内瘤变(Cervical intraepithelial neoplasia,CIN),初步了解此类患者中TCT及HPV感染情况与妊娠宫颈病变的关系。方法:对象为2006年1月至2012年1月确诊为妊娠合并宫颈上皮内瘤变的72例患者,初次孕期保健均进行细胞学、HPV检测,对这些临床资料进行回顾性分析研究。结果:妊娠合并CIN发生率为2.1%。72例患者中全部产前行宫颈TCT检测,HSIL为32例,LSIL为40例,56例于产前保健时检测HPV,其中48例(85.7%)为阳性结果,32例为HPV16型单独或混合感染。72例孕期保健时行阴道镜活检病理诊断CINⅠ16例、CINⅡ16例、CINⅢ40例。结论:液基细胞学联合HPV分型检测在妊娠合并宫颈上皮内瘤变患者的应用是安全而且有效的。在妊娠期CIN患者中HPV感染率高,且HPV16型与CIN高等级病变关系密切。 Objective: The present study aimed to investigate the relationship between cervical intraepithelial neoplasia (CIN) and human papilloma virus (HPV) infection during pregnancy using liquid-based cytology and HPV test. Methods: We prospectively studied the clinical data of 72 pregnant women with CIN who were hospitalized between January 2006 and January 2012 at Tangshan Gongren Hospital. All patients underwent liquid-based thin-layer cytology technique and/or HPV test. Results: Thirty two cases, which included 16 cases each of CIN Ⅰ and Ⅱ, displayed high-grade squamous intraepithelial lesion. The other 40 cases were CIN Ⅲcharacterized by low-grade squamous intraepithelial lesion based on biopsy pathology through colposcopy. A total of 48 (85.7% ) HPV-positive cases were determined among 56 antenatal patients. Moreover, 32 of the 48 HPV-positive cases had either HPV16 infection alone or a mixture of different infection types. Conclusion: Results indicated that the CIN pregnant patients exhibited high frequency of HPV infections, and its HPV16 type is closely associated with the pathological development of high-grade lesions.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第7期395-397,共3页 Chinese Journal of Clinical Oncology
关键词 宫颈液基细胞学 人乳头瘤病毒 宫颈上皮内瘤变 妊娠 liquid-based thin-layer cervical cytology, human papilloma virus, cervical intraepithelial neoplasia, pregnancy
  • 相关文献

参考文献15

二级参考文献26

  • 1Wright TC, Cox Jr JT, Massad S, et al. 2001 Consensus guideline for the management of women with cervical intraepithelial neoplasia[ J]. Journal of Lower Genital Tract Disease ,2003,7 (3) :154 - 167.
  • 2Brismar-Wendel S, Froberg M , Hjerpe A, et al. Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions [ J ]. British Journal of Cancer, 2009, 21 ( 7 ) : 511 -517.
  • 3Idestrom M, Milsom I, Andersson-Ellstrom A. Women's experience of coping with a positive Pap smear : a register-based study of women with two consecutive Pap smears reported as CINI [ J ]. Acta Obstet GynecoI Scand ,2003,82 ( 8 ) :756 - 761.
  • 4Ane C, Batmaz G, Dane B,et al. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study [ J ]. Ann Diagn Pathol,2009,13(2) :73 -77.
  • 5Thomas C, Wright L, Massad S, et al. 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests [ J ]. Am J Obeste Gynecol,2007,197 ( 4 ) : 346 - 355.
  • 6Kiatpongsan S, Niruthisard S, Mutirangura A, et al. Role of hunman papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance[ J]. Int J Gynecol Cancer,2006,16 ( 1 ) :262 - 265.
  • 7Chen W, Zhang X, Molijin A, et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18 [ J]. Cancer Causes Control,2009,20 (9) : 1705 - 1713.
  • 8Walboomers JM, Jacobs MV, Manos MM, et al. Human pappillomavirus is necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999,189 ( 1 ) : 12 - 19.
  • 9Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries [ J ]. Vaccine, 2008, 26 (Suppll0) : K29 - K41.
  • 10回允中主译.女性生殖道病理学[M].北京:北京大学医学出版社,2005.795-797.

共引文献79

同被引文献122

  • 1张传英,王敏.妊娠期宫颈上皮内瘤变的筛查和处理进展[J].实用妇产科杂志,2007,23(9):517-519. 被引量:19
  • 2Remondi C,Sesti F,Bonanno E,et al.Diagnostic accuracy of liquid based endometrial cytology in the evaluation of endometrial pathology in postmenopausal women[J].Cytopathology,2012,doi:10.1111/cyt.12013.
  • 3Fujiwara A,Nagayama S,Amada S,et al.Intravascular large B-cell lymphoma involving mainly the uterus:report of a case using liquid based cytology of the endometrium[J].Acta Cytol,2010,54(5 Suppl):787-792.
  • 4Norimatsu Y,Kouda H,Kobayashi TK,et al.Utility of liquid based cytology in endometrial pathology:diagnosis of endometrial carcinoma[J].Cytopathology,2009,20(6):395-402.
  • 5Watanabe J,Nishimura Y,Tsunoda S,et al.Liquid based preparation for endometrial cytology usefulness for predicting the prognosis of endometrial carcinoma preoperatively[J].Cancer,2009,25,117(4):254-263.
  • 6van Alewijk D,Kleter B,Vent M. A human papilloma virus testing algorithm comprising a conbination of the LI broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specificgenotyping PCR assay[J].{H}Journal of Clinical Microbiology,2013,(4):1171-1178.
  • 7Candelier J J, Frappart L, Diatta A L, et al.Differential expression of E-cadherin, 13 -catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas[J].Virchows Archiv, 2013, 45 (8): 1-11.
  • 8Tarka A, Szczepafiska M, Rokita W, et al.Risk assessment of chronic HPV HR infection in babies who contacted the virus in the perinatal period[Jl.Ginekol Pol, 2011, 82 ( 9 ) : 664-669.
  • 9Arbyn M; Castellsagu - X, de Sanjos - S, et aL Worldwide burden of cervical cancer in 2008. Ann Oncol,2011,22(12):2675-2686.
  • 10Chen H, Shu HM, Chang ZL, et al. Efficacy of Pap test in combination with ThinPrep cytological test in screening for cervical cancer . Asian Pac J Cancer Prev,2012,13(4):1651-1655.

引证文献12

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部